• Xenon Pharmaceuticals granted equity inducement awards to 10 new non-officer employees, totaling 32,750 share options, 19,200 RSUs.
• Options carry a $54.79 exercise price, matching the May 28, 2026 close; each option has a 10-year term.
• Options vest over four years: 25% after year one, then monthly for the remaining 36 months, subject to continued service.
• RSUs vest 25% on each of the first four anniversaries of the employee’s start date, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenon Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605291601PRIMZONEFULLFEED9728925) on May 29, 2026, and is solely responsible for the information contained therein.